Literature DB >> 12587443

[Elective resection of the spleen--overview of resection technics and description of a new technic based on radiofrequency coagulation and dessication].

M Milićević1, P Bulajić, M Zuvela, Z Raznatović, V Obradović, N Lekić, I Palibrk, D Basarić.   

Abstract

The authors present a short overview of the development of elective splenic resections. Past and present indications are presented. Contemporary hemostatic technique for elective splenic resection are discussed. An original new technique for transsegmental partial splenic resection using RF generator Radionic Cool Tip(without any aditional hemostatic procedures is presented. This technique is inovative and when use properly it is a practically zero blood loos technique. A patient with transsegmental splenic resection using RF generator is presented. Further clinical application of the technique is necessary.

Entities:  

Mesh:

Year:  2002        PMID: 12587443     DOI: 10.2298/aci0203019m

Source DB:  PubMed          Journal:  Acta Chir Iugosl        ISSN: 0354-950X


  3 in total

1.  Pancreatic metastases from renal cell carcinoma: the state of the art.

Authors:  Roberto Ballarin; Mario Spaggiari; Nicola Cautero; Nicola De Ruvo; Roberto Montalti; Cristina Longo; Anna Pecchi; Patrizia Giacobazzi; Giuseppina De Marco; Giuseppe D'Amico; Giorgio Enrico Gerunda; Fabrizio Di Benedetto
Journal:  World J Gastroenterol       Date:  2011-11-21       Impact factor: 5.742

2.  Intraoperative radiofrequency ablation combined with 125 iodine seed implantation for unresectable pancreatic cancer.

Authors:  Yi-Ping Zou; Wei-Min Li; Fang Zheng; Fu-Cheng Li; Hui Huang; Ji-Dong Du; Hao-Run Liu
Journal:  World J Gastroenterol       Date:  2010-10-28       Impact factor: 5.742

3.  Results of 100 pancreatic radiofrequency ablations in the context of a multimodal strategy for stage III ductal adenocarcinoma.

Authors:  Roberto Girelli; Isabella Frigerio; Alessandro Giardino; Paolo Regi; Stefano Gobbo; Giuseppe Malleo; Roberto Salvia; Claudio Bassi
Journal:  Langenbecks Arch Surg       Date:  2012-09-29       Impact factor: 3.445

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.